Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS)

Stock Information for Ainos Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ainos Inc.

The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments
Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain
Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026
Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity
Ainos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production Environments
Ainos Initiates Live AI Nose Deployments within Semiconductor Manufacturing Environments
Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion
Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.